Concepedia

LBA15 Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer

C. Saura Manich, Joyce O’Shaughnessy, Philippe Aftimos, Evelyn van den Tweel, M. Oesterholt, Santiago Escrivá-de-Romaní, N. Quenel Tueux, T.J.Y. Tan, Joline S.J. Lim, Sylvain Ladoire,

Annals of Oncology · 2021 · 104 citations · 0 references

DOI

Concepts